Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jazz Pharmaceuticals PLC

101.18
-9.9900-8.99%
Volume:1.97M
Turnover:206.08M
Market Cap:6.14B
PE:11.70
High:109.08
Open:105.30
Low:100.85
Close:111.17
Loading ...

Jazz Pharmaceuticals Cut to Neutral From Overweight by Cantor Fitzgerald

Dow Jones
·
27 Feb

Jazz downgraded to Neutral at Cantor on oncology strategy ‘head-scratcher’

TIPRANKS
·
27 Feb

Jazz Pharmaceuticals downgraded to Neutral from Overweight at Cantor Fitzgerald

TIPRANKS
·
27 Feb

Jazz Pharmaceuticals Price Target Raised to $176.00/Share From $163.00 by Piper Sandler

Dow Jones
·
27 Feb

Stock Track | Jazz Pharmaceuticals Soars 5.05% on Positive Earnings, Analyst Upgrades

Stock Track
·
27 Feb

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term

Zacks
·
26 Feb

Jazz Pharmaceuticals (JAZZ) Gets a Buy from Bank of America Securities

TIPRANKS
·
26 Feb

Stifel Nicolaus Remains a Buy on Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
26 Feb

Jazz Pharmaceuticals price target raised to $167 from $162 at Baird

TIPRANKS
·
26 Feb

RBC Trims Price Target on Jazz Pharmaceuticals to $178 From $179, Keeps Outperform Rating

MT Newswires Live
·
26 Feb

Jazz Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
26 Feb

Despite the downward trend in earnings at Jazz Pharmaceuticals (NASDAQ:JAZZ) the stock advances 3.2%, bringing five-year gains to 21%

Simply Wall St.
·
26 Feb

Jazz Pharmaceuticals PLC (JAZZ) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...

GuruFocus.com
·
26 Feb

Jazz Pharmaceuticals Plc : JP Morgan Raises Target Price to $209 From $200

THOMSON REUTERS
·
26 Feb

Jazz Pharmaceuticals Plc : TD Cowen Raises Target Price to $205 From $195

THOMSON REUTERS
·
26 Feb

Jazz Pharmaceuticals PLC reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
26 Feb

Compared to Estimates, Jazz (JAZZ) Q4 Earnings: A Look at Key Metrics

Zacks
·
26 Feb

Jazz Pharmaceuticals (JAZZ) Tops Q4 Earnings and Revenue Estimates

Zacks
·
26 Feb

Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 Sales

StockStory
·
26 Feb

Jazz Pharmaceuticals Q4 Non-GAAP Earnings, Revenue Rise; 2025 Guidance Issued

MT Newswires Live
·
26 Feb